BioPharma Credit PLC provided dividend guidance for the full year ending December 31, 2023. For the period, the company's target dividend of 7 cents per annum (December 31, 2022: 7 cents per annum).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.876 USD | -0.23% | -0.45% | +4.29% |
May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
May. 02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.29% | 1.07B | |
+5.79% | 12.87B | |
-0.20% | 5.6B | |
+5.94% | 5.48B | |
+6.71% | 5.23B | |
+23.14% | 4.86B | |
+20.22% | 4.64B | |
+2.49% | 4.11B | |
+7.31% | 4.01B | |
-0.18% | 3.28B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- BioPharma Credit PLC Provides Dividend Guidance for the Full Year Ending December 31, 2023